Mr
David
Akerman

Trainee Patent Attorney

Newcastle Office

Telephone. +44(0) 191 205 8360
Email. [email protected]

Experience

Before joining HGF, David gained 20 years' IP management experience through in-house roles in textile and consumer-goods companies, making significant investment in innovation.

David’s IP experience includes undertaking freedom to operate searches, patent licensing, and developing IP strategies. He has also had involvement in IP due diligence in company and asset purchase projects.

In his in-house roles, David had significant involvement in contentious IP matters in Europe, USA and Japan, including patents, designs, trade dress, breach of confidence and know how.

After graduating from the University of Manchester, Institute of Science and Technology with an honours degree in Chemistry, David stayed on to undertake a PhD in Textile Chemistry. His research investigated the mechanism of oxidative bleaching of dyed cotton substrates during domestic laundering. The project was funded by industry and led to the publication of a patent application and three academic papers.

Specialisms

  • Baby & infant products

Industries

  • Automotive icon Automotive
  • CleanTech icon CleanTech
  • Medical devices icon Medical devices

Services

  • Due diligence
  • In-house legal support
  • Patents
  • Portfolio management
  • Searching & competitor monitoring
  • Strategy

Qualifications

Trainee


BSC

Chemistry

PHD

Textile Chemistry

POSTGRADUATE DIPLOMA OR CERTIFICATE

PG Certificate in Intellectual Property

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details
Event - 25th May 2021

IAM webinar: How to capitalise on the 5G healthcare revolution

HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.